Transcriptome-wide m 6 A mapping reveals the presence of m 6 A modification in approximately 7,000 mRNAs in both human and mouse transcriptomes and uncovers the consensus motif RRACH (in which R denotes G or A; and H denotes A, C or U) in which A is converted to m 6 A [13][14][15] . Despite the recognition of RRACH motifs by the METTL3-METTL14 methyltransferase complex in vitro, only a portion of these motifs are methylated in vivo, and such modifications typically occur in the coding sequence (CDS) and 3′-untranslated region (UTR) [13][14][15][16] . How individual transcripts and specific sites are selected for proper deposition of m A peaks overlapped with the H3K36me3 modification (Extended Data Fig. 1a ). Distance analysis also showed an overrepresentation of H3K36me3 modification, but not H3K27me3 (as a control), near m 6 A peaks (Extended Data Fig. 1b ). Given that, to our knowledge, H3K36me3 is the only known histone modification enriched in the CDS and especially near the 3′ end 17,18 , these results revealed a possible unappreciated connection between H3K36me3 and m 6 A RNA modification. Moreover, the histone methyltransferase SET domain containing 2 (SETD2), which specifically catalyses the conversion of H3K36me2 to H3K36me3 (Fig. 1a and Extended Data Fig. 2a-k) . This effect seems to be conserved in mammals, as heterozygous knockout of SETD2 in mouse c-Kit + bone marrow cells also led to hypomethylation of both H3K36me3 and m 6 A (Extended Data Fig. 2l-o) . By contrast, knockdown of the H3K9me3 methyltransferase SUV39H1 did not affect m 6 A abundance (Extended Data Fig. 2p-r) . Gain-of-function experiments in SETD2-deficient human A498 cells showed that the co-transcriptional catalytic activity of SETD2 is required for the restoration of H3K36me3 and m 6 A levels ( Fig. 1b and Extended Data Fig. 2s-u) . Conversely, however, silencing of the m 6 A MTC genes did not affect cellular H3K36me3 levels (Extended Data Fig. 2v) . Collectively, these results imply a causal role of H3K36me3 on m 6 A deposition, and suggest that the loss of H3K36me3 impaired de novo m 6 A methylation. We performed m 6 A sequencing (m 6 A-seq) in parallel with H3K36me3 chromatin immunoprecipitation followed by sequencing (ChIP-seq) in SETD2-knockdown cells to evaluate the global effect of H3K36me3 on m 6 A deposition. ChIP-seq analysis confirmed the global reduction of H3K36me3, especially around stop codons, in SETD2-knockdown cells (Extended Data Fig. 3a-e) . Meanwhile, m 6 A-seq analysis revealed a global hypomethylation of m 6 A in the transcriptome after SETD2 depletion (Fig. 1c and Extended Data Fig. 3f-i) . Similarly, these m 6 A-hypomethylated peaks were mostly found in protein-coding mRNAs and enriched near stop codons (Extended Data  Fig. 3j, k) . The most common m 6 A consensus sequence 'GGAC' was 
A in mRNA, and uncover another layer of gene expression regulation that involves crosstalk between histone modification and RNA methylation.
Transcriptome-wide m 6 A mapping reveals the presence of m 6 A modification in approximately 7,000 mRNAs in both human and mouse transcriptomes and uncovers the consensus motif RRACH (in which R denotes G or A; and H denotes A, C or U) in which A is converted to m 6 A [13] [14] [15] . Despite the recognition of RRACH motifs by the METTL3-METTL14 methyltransferase complex in vitro, only a portion of these motifs are methylated in vivo, and such modifications typically occur in the coding sequence (CDS) and 3′-untranslated region (UTR) [13] [14] [15] [16] . How individual transcripts and specific sites are selected for proper deposition of m A in the human transcriptome to that of different histone modifications, we found that 69.2% of m 6 A peaks overlapped with the H3K36me3 modification (Extended Data Fig. 1a ). Distance analysis also showed an overrepresentation of H3K36me3 modification, but not H3K27me3 (as a control), near m 6 A peaks (Extended Data Fig. 1b ). Given that, to our knowledge, H3K36me3 is the only known histone modification enriched in the CDS and especially near the 3′ end 17, 18 , these results revealed a possible unappreciated connection between H3K36me3 and m 6 A RNA modification. Moreover, the histone methyltransferase SET domain containing 2 (SETD2), which specifically catalyses the conversion of H3K36me2 to H3K36me3 A abundance (Extended Data Fig. 2p-r) . Gain-of-function experiments in SETD2-deficient human A498 cells showed that the co-transcriptional catalytic activity of SETD2 is required for the restoration of H3K36me3 and m 6 A levels . Conversely, however, silencing of the m 6 A MTC genes did not affect cellular H3K36me3 levels (Extended Data Fig. 2v ). Collectively, these results imply a causal role of H3K36me3 on m 6 A deposition, and suggest that the loss of H3K36me3 impaired de novo m 6 A methylation. We performed m 6 A sequencing (m 6 A-seq) in parallel with H3K36me3 chromatin immunoprecipitation followed by sequencing (ChIP-seq) in SETD2-knockdown cells to evaluate the global effect of H3K36me3 on m 6 A deposition. ChIP-seq analysis confirmed the global reduction of H3K36me3, especially around stop codons, in SETD2-knockdown cells (Extended Data Fig. 3a-e) . Meanwhile, m 6 A-seq analysis revealed a global hypomethylation of m 6 A in the transcriptome after SETD2 depletion ( Fig. 1c and Extended Data Fig. 3f-i) . Similarly, these m 6 A-hypomethylated peaks were mostly found in protein-coding mRNAs and enriched near stop codons (Extended Data Fig. 3j, k) . The most common m 6 A consensus sequence 'GGAC' was Letter reSeArCH enriched in these m 6 A-hypomethylated peaks with the highest ratio (Extended Data Fig. 3l ). Consistent results were also obtained with m 6 A individual-nucleotide-resolution cross-linking and immunoprecipitation (miCLIP) 15 analysis and subsequent sequencing (Extended Data Fig. 3m-q) .
Integrated analysis of ChIP-seq and m 6 A-seq data revealed that the chromosome positions of H3K36me3 and m 6 A were well correlated (z-score = 212.93, P = 9.99 × 10 −4
, permutation test; Extended Data Fig. 4a ) and overlapped (Fig. 1d) . Notably, the distributions of H3K36me3 and m 6 A were mostly exclusive with those of the heterochromatin markers H3K9me3 or H3K27me3 (Extended Data Fig. 4a-c) . Further analyses revealed that the m 6 A peaks associated with H3K36me3 modifications (H3K36me3 A−) tend to be enriched in the CDS and intronic regions rather than at the 3′ end (Extended Data Fig. 4e ); such (m 6 A−) H3K36me3 modifications may mediate deacetylation, splicing and prevention of runaway transcription as reported [21] [22] [23] . In loci where H3K36me3 and m 6 A are both present, 2,717 out of the 5,872 (46.3%) hypomethylated (fold change < 0.5) H3K36me3 peaks after SETD2 knockdown also exhibit m 6 A hypomethylation (fold change < 0.5), whereas only 427 (7.3%) hypomethylated H3K36me3 peaks exhibit m 6 A hypermethylation (fold change > 2). Such co-regulation of H3K36me3 and m 6 A by SETD2 knockdown was confirmed in individual representative genes, such as MYC, ACTB, KPNA6 and EEF1A (Fig. 1e, f and Extended Data Fig. 4f-i) , similar to what was observed when KDM4A was overexpressed (Extended Data Fig. 4j, k) .
We further used the CRISPR-dCas9 fusion system-in which nucleasedeactivated Cas9 (dCas9) is directed by single-guide RNAs (sgRNAs) and thus brings the fused protein to specific genomic regions for epigenetic modification 24 -to confirm the casual regulation of H3K36me3 on m 6 A deposition at a specific locus (Extended Data Fig. 5a, b) .
As expected, co-expression of the dCas9-KDM4A fusion protein with sgRNAs targeting the coding region instability determinant (CRD) of MYC, where high levels of H3K36me3 were observed (Fig. 1e) , could partially remove H3K36me3 and subsequently impair m 6 A deposition on MYC mRNA (Fig. 1g) . Conversely, co-expression of the dCas9-SETD2 fusion with sgRNAs targeting the gene body of GNG4, where no detectable H3K36me3 and m 6 A modifications were found (Extended Data Fig. 5c ), increased the abundance of H3K36me3 in the GNG4 gene body and m 6 A modification in the corresponding mRNA region (Fig. 1h) . Moreover, we constructed an artificial fusion gene (MYC-GNG4) in which the 5′ UTR sequence of GNG4 was fused downstream of the MYC CRD (Extended Data Fig. 5d ). We presumed that this MYC-GNG4 fusion would result in increased H3K36me3 modifications owing to the elongation of polymerase (Pol) II and co-transcriptional deposition of H3K36me3 25 . This was indeed the case, and more importantly, such fusion resulted in increased levels of m 6 A modifications that could be partially or completely abrogated by depletion of SETD2 (Extended Data Fig. 5e ), further demonstrating that m 6 A modifications could be guided by H3K36me3. We then compared the transcriptome-wide effect of SETD2 knockdown on m 6 A modification to that caused by knockdown of individual m 6 A MTC components (Fig. 2a) . A given m 6 A site that displayed a more than 1.5-fold reduction after knockdown of a given m 6 A MTC gene was defined as the MTC gene-responsive site. Among the SETD2-dependent m 6 A-hypomethylated sites, 84% were responsive to the depletion of one or more individual MTC genes (Fig. 2a) . SETD2 silencing led to a global m 6 A hypomethylation on METTL3-, METTL14-, or WTAP-responsive sites, and particularly on the sites responsive to all three MTC genes (Fig. 2b) , and such reduction mainly occurred within the CDS and 3′ UTR (Fig. 2c) , as demonstrated by MYC mRNA (Extended Data Fig. 6a ). Moreover, a significant positive correlation (r = 0.51-0.60, P < 2.22 × 10 (Fig. 2d) . RNA sequencing (RNA-seq) analysis revealed that knockdown of SETD2 or of individual MTC genes suppressed gene expression (Extended Data Fig. 6b ), and their effects on 6 A (right) levels at specific loci were detected in HEK293T cells co-transfected with dCas9-KDM4A (g) or dCas9-SETD2 (h) and specific sgRNAs or non-targeting control (sgNT) as indicated. Data are mean ± s.d. of four independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001; two-tailed Student's t-test.
Letter reSeArCH the alterations of gene expression showed a significant positive correlation (r = 0.52-0.58, P < 2.22 × 10 −308
, Extended Data Fig. 6c ). Further mRNA stability profiling and polysome profiling showed that SETD2 knockdown phenocopied METTL14 knockdown in affecting mRNA decay and translation (Extended Data Fig. 6d-h ).
Mechanistically, we found that depletion of H3K36me3 by SETD2 silencing impaired the interaction between m A MTC proteins was detected independent of RNA or DNA ( Fig. 3a and Extended Data Fig. 7g, h ). The binding seemed to be specific to H3K36me3, with no interaction observed between METTL14 and H3K36me1 or H3K36me2 (Extended Data Fig. 7i ). The interaction between H3K36me3 and endogenous METTL3 or METTL14 was also validated (Extended Data Fig. 7j, k) . Furthermore, silencing of individual m 6 A MTC components in cellulo showed that depletion of METTL14, but not of METTL3 or WTAP, impaired the interaction of the MTC with H3K36me3 (Extended Data Fig. 7k ), suggesting that METTL14 is essential for the binding of the MTC to H3K36me3. Moreover, the effect of SETD2 knockdown on m 6 A reduction was largely impaired in the absence of METTL14 (Extended Data Fig. 7l) .
We proposed two possible models that underlie this interactionindirect (through adaptors) or direct (reading and writing) binding (Extended Data Fig. 8a ). The indirect model was excluded because no known H3K36me3 readers (adaptors) tested could affect the binding of H3K36me3 to METTL14 (Extended Data Fig. 8b-d) . Instead, our in vitro (cell-free) pull-down and gel-shift assays revealed a direct interaction between H3K36me3 and recombinant METTL14 protein ( Fig. 3b and Extended Data Fig. 8e, f) . Microscale thermophoresis 26, 27 was performed to evaluate the binding affinity, which gave an estimated dissociation constant (K d ) value of 1.860 ± 0.288 µM (mean ± s.d.) (Fig. 3c) .
To determine which region in METTL14 contributes to its binding to H3K36me3, we conducted truncation analysis using immunoprecipitation (Extended Data Fig. 8g ). Among the truncations, Δ186-456 is the shortest variant that could interact with H3K36me3 (Extended Data Fig. 8g, h ), suggesting that amino acids 1-185 are crucial for the binding. Two fragments of METTL14, amino acids 138-143 and 153-161, were found to be important for the binding (Extended Data  Fig. 8i) . Functionally, only full-length but not truncated variants of METTL14 (Δ138-143 or Δ153-161) could restore the m 6 A abundance in METTL14-inducible knockout cells (Extended Data Fig. 8j) .
Because METTL14 interacts with H3K36me3, we speculate that it also binds to chromatin. ChIP-seq analysis with haemagglutinin (HA)-tagged METTL14 using an anti-haemagglutinin antibody identified 1,973 peaks in HepG2 cells, among which 1,278 (65%) were located in the gene body (Fig. 3d ). We revealed a significant genome-wide correlation between chromatin binding of METTL14 to H3K36me3, but not to H3K27me3 ( Fig. 3e and Extended Data Fig. 8k ). In addition, photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) sequencing revealed 5,981 potential METTL14-binding sites on RNA (Extended Data Fig. 8l-n) . Distance analysis showed that METTL14-binding sites on RNA overlapped with H3K36me3 and m 6 A modifications (Fig. 3f, g ), supporting our proposed function of METTL14 in linking H3K36me3 with m 6 A deposition.
In line with previous reports that H3K36me3 was established by SETD2 when associated with Pol II during transcription elongation 25 , we demonstrated the association of m 6 A MTC proteins with Pol II (Fig. 3a and Extended Data Fig. 7h ), and specifically, the elongating form of Pol II (phosphorylated at Ser2) (Extended Data Fig. 8o ). We found that METTL14 co-localizes with H3K36me3 and pSer2-Pol II in the nucleus (Extended Data Fig. 8p ), supporting a co-transcriptional regulation of H3K36me3 on m 6 A deposition. In addition, newly transcribed RNAs associated with chromatin exhibited higher abundance of m 6 A modification than nucleoplasmic or cytoplasmic RNAs (Extended Data Fig. 8q ). To understand this process better, we treated cells with the Pol II inhibitor 5,6-dichlorobenzimidazole-1-β-d-ribofuranoside (DRB) for a short time (3 hours). DRB treatment decreased m 6 A abundance without affecting H3K36me3 (Extended Data Fig. 8r-t) . Notably, the interaction of METTL14 with H3K36me3, chromatin or METTL3 was not interrupted by DRB treatment (Extended Data Fig. 8u, v) . Therefore, our results suggest a working model in which METTL14, a crucial component of the m 6 A MTC, directly reads H3K36me3 in a Pol II-independent manner, and this allows the m 6 A MTC to methylate adjacent nascent RNAs during Pol II-mediated transcription elongation (Fig. 3h) .
Dynamic regulation of m 6 A modifications is crucial for the selfrenewal and differentiation of embryonic stem (ES) cells [5] [6] [7] . To determine whether the regulation of H3K36me3 on m 6 A RNA modification influences cell differentiation, we used a doxycycline-inducible SETD2-knockdown mouse ES cell model (Extended Data Fig. 9a, b) , and assayed cell differentiation in vitro by the withdrawal of leukaemia inhibitory factor (LIF). After doxycycline treatment, mouse ES cells expressed higher levels of pluripotency factors, such as OCT4 (also known as POU5F1), SOX2 and NANOG (Fig. 4a) , and showed stronger staining of cell-surface SSEA1 and nuclear OCT4 (Extended Data  Fig. 9c) , suggesting a more primitive state. By contrast, the increase in expression of endoderm markers (that is, GATA4, GATA6, DAB2 and SOX7) during differentiation was attenuated by the presence of doxycycline (Extended Data Fig. 9d ). The effects of SETD2 knockdown on mouse ES cell differentiation were similar to those caused by METTL14 knockdown (Extended Data Fig. 9e-g ).
As expected, global H3K36me3 and cellular m 6 A levels were substantially reduced in mouse ES cells after SETD2 knockdown (Extended Data Fig. 9h-m) . Notably, most of the genes with H3K36me3 hypomethylation showed significantly reduced m 6 A levels ( Fig. 4b ; P < 2.22 × 10 −16 by Pearson's chi-squared test), as represented by the Sox2 mRNA transcript (Fig. 4c, d ). Functional analysis of gene expression revealed the enrichment of stem-cell maintenance genes among Letter reSeArCH the downregulated genes during LIF withdrawal and the upregulated genes after SETD2 silencing (Extended Data Fig. 9n ). In representative pluripotency genes with a significant decrease of H3K36me3 after SETD2 knockdown, an increase in m 6 A levels was observed during cell differentiation, and this was prevented by doxycycline-induced SETD2 knockdown (Fig. 4e and Extended Data Fig. 9o) . Consistent with the reported role of m 6 A in destabilizing mRNAs (especially in ES cells) 2 , these pluripotency genes showed a marked decrease in mRNA expression during differentiation, and this could be partially rescued by SETD2 knockdown (Extended Data Fig. 9p ). These results indicate that loss of H3K36me3 reduces m 6 A in mouse ES cells, and inhibits cell differentiation in vitro. Furthermore, the knockdown of METTL14 in SETD2-silenced cells could moderately inhibit cell differentiation further (Extended Data Fig. 10a-c) . Conversely, the overexpression of METTL14 promoted differentiation in control cells, and could partially rescue the inhibition of differentiation in SETD2-knockdown cells (Extended Data Fig. 10d-f) . Collectively, our results reveal that SETD2 and H3K36me3 inhibit pluripotency and promote the differentiation of mouse ES cells at least in part through the regulation of m 6 A modification on several crucial pluripotency genes.
In summary, we uncover a mechanism that underlies the dynamic, specific and co-transcriptional deposition of m 6 A modification in mammalian transcriptomes, explaining its prevalent occurrence in the CDS and 3′ UTR. The identification of the histone mark H3K36me3 as a determinant of m 6 A RNA modification via METTL14 reveals a cross-talk between histone modification and RNA methylation, and adds another layer of complexity to the control of gene expression in normal and pathological biological processes.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Code availability
Code used for data analysis including cutadapt v. 
Data availability
All sequencing data that support the findings of this study have been deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GSE110323. Previous published ChIP-seq data and m 6 A-seq data of HepG2 cells were re-analysed and are available under GEO accession codes GSE51334 and GSE37003. Previously published ENCODE data that were re-analysed here are available under accession codes ENCFF533JQH, ENCSR000ATD (H3K9me3) and ENCFF042EDV, ENCSR000DUE (H3K27me3) for heterochromatin and window correlation analysis. The expression data of SETD2 and MTC genes were derived from the TCGA Research Network (http://cancergenome.nih.gov/), GTEx program (https://www.gtexportal.org/), and CCLE project (https://portals.broadinstitute.org/ccle). The dataset derived from this resource that supports the findings of this study is available in the ChIPbase (http://rna.sysu.edu.cn/chipbase/) 29,30 and CCLE (https://portals.broadinstitute.org/ccle) websites.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-1016-7. Nat. Cell Biol. 16, 191-198 (2014 
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Data analysis
Microsoft excel 2016 was used to calculate mean, standard deviation and P value. TotalLab 2.0 was used to quantify signal of gel shift assay. The NTAnalysis from NanoTemper was used to calculate binding fraction and the dissociation constant (KD). The custom Perl and R scripts used in this study are available on request to the corresponding authors.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data

